GENEVA, July 3 -- REDHILL BIOPHARMA LTD. (21 Ha'arba'a St.Tel-Aviv) filed a patent application (PCT/IB2024/000726) for "COMBINATION THERAPY FOR INHIBITION OF EBOLAVIRUS" on Dec 17, 2024. With publication no. WO/2025/133697, the details related to the patent application was published on Jun 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): FATHI, Reza (21 Ha'arba'a St.Tel-Aviv), BEN-ASHER, Dror (21 Ha'arba'a St.Tel-Aviv), GOLDBERG, Guy (21 Ha'arba'a St.Tel-Aviv)
Abstract:
Combination therapies for the inhibition of single-stranded RNA virus replication, such as ebolaviruses are disclosed...